BIOMEDICA

Welcome to the Brand page for “BIOMEDICA”, which is offered here for Gene therapy products for medical use, clinical medical reagents, liposome reagents, nucleic acids, and vaccines for use in gene therapy, gene-based medicines, chemotherapeutics, and pharmaceutical preparations for use in the treatment of viral and bacterial infections, cancer, hiv and aids related infections, bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, vascular disorders and disorders arising from inappropriate vascularisation, diseases of the nervous system, neuro-degenerative disorders, cardiac disorders, cystic fibrosis, inflammatory and auto-immune diseases; enzymes and enzyme preparations for medical purposes for use in gene delivery technologies; retroviral vector manufacturing preparations and retroviral vector preparations for medical use for gene delivery technologies; chemical products for medical use for genetic engineering and in gene therapy; none of the foregoing goods including or for use in connection with immunoassay diagnostic test devices containing reagent test strips for detecting the presence of drugs of abuse in saliva or urine specimens;bio medica;chemical products for use in industry and science for use in gene delivery technology and the manufacture of pharmaceuticals and retroviral vector preparations; enzymes for laboratory and research use; chemical products for in vitro use in laboratories and for analysis, for use in gene delivery technology, micro-organisms for laboratory and research use, cell cultures for laboratory and research use, plasmids and cultures of micro-organisms for laboratory and research use, deoxyribonucleic acid sequences for laboratory and research use, cloning vehicles, chemical preparations for scientific purposes for use in biotechnology, research and development and recombinant deoxyribonucleic acid variations thereof for laboratory and research use, all for in vivo use; none of the goods in this class for medical or veterinary purposes; none of the foregoing goods including or for use in connection with the immunoassay diagnostic test devices containing reagent test strips for detecting the presence of drugs of abuse in saliva or urine specimens;medical services;instruments and apparatus for the administration of gene therapy products, injection devices, syringes, scalpels, catheters, tubes for the administration of gene therapy products; surgical and medical apparatus and instruments, injection devices, syringes, scalpels, catheters, tubes for medical services, none being blood circulatory apparatus and instruments, blood pumps, flow probes for blood pumps or blood circulatory devices for medical purposes;scientific and medical research in the fields of genetic engineering and gene therapy and scientific and medical development in the fields of genetic engineering and gene therapy, genetic engineering services and gene therapy and prophylaxis for the development and commercialization of therapeutic vaccines and gene-based therapies, development of new technology for others in the field of biotechnology, collaboration for others with other biomedical and pharmaceutical entities for the commercialization of therapeutic vaccines and gene-based therapies; none of the foregoing services including or for use in connection with the immunoassay diagnostic test devices containing reagent test strips for detecting the presence of drugs of abuse in saliva or urine specimens;.

Its status is currently believed to be active. Its class is unavailable. “BIOMEDICA” is believed to be currently owned by “Oxford BioMedica plc”.